Obstructive sleep apnoea is when breathing is repeatedly interrupted during sleep. Research has shown people with this sleep disorder have an increased risk of developing cognitive impairment and Alzheimer’s disease. Yet, it is treatable. A preliminary study released today has found that obstructive sleep apnoea is common in people with cognitive impairment. The study will be presented at the American Academy of Neurology’s 73rd Annual Meeting being held virtually on 17th–22nd April 2021.
Cognitive impairment includes memory and thinking problems that affect concentration, decision-making and learning new things. The risk of cognitive impairment increases as people age.
‘Better sleep is beneficial to the brain and can improve cognitive skills. Yet in our study, we found that over half of the people with cognitive impairment had obstructive sleep apnoea,’ said study author Mark Boulos, MD, of the University of Toronto in Canada and member of the American Academy of Neurology. ‘We also found that those with the sleep disorder had lower scores on thinking and memory tests. Fully understanding how obstructive sleep apnoea affects this population is important because with treatment, there is potential to improve thinking and memory skills as well as overall quality of life.’
The study involved 67 people with an average age of 73 who had cognitive impairment. Participants completed questionnaires on sleep, cognition, and mood. They also took a 30-point cognitive assessment to determine their level of cognitive impairment. Questions included identifying the date and the city they were in and repeating words they had been asked to remember earlier in the test. Scores on the test range from zero to 30. A score of 26 or higher is considered normal, 18-25 signifies mild cognitive impairment and 17 or lower signifies moderate to severe cognitive impairment.
Participants were given at-home sleep apnoea tests to determine if they had obstructive sleep apnoea. The at-home test uses a monitor to track breathing patterns and oxygen levels during sleep.
Researchers found that 52% of study participants had obstructive sleep apnoea. People with the sleep disorder were 60% more likely to score lower on the cognitive test than people who did not have sleep apnoea. People with the disorder had an average score of 20.5 compared to an average score of 23.6 for the people without the sleep disorder.
In addition, researchers found that the severity of obstructive sleep apnoea corresponded with the degree of cognitive impairment as well as the quality of sleep for participants, including sleep time, how quickly they fell asleep, the efficiency of their sleep and how often they awoke at night.
‘People with cognitive impairment should be assessed for obstructive sleep apnoea because it can be treated by using a continuous positive airway pressure (CPAP) machine that helps keep the airway open at night,’ said Boulos. ‘However, not everyone who tries CPAP chooses to regularly use the therapy, and this may be a bigger challenge to people with thinking and memory problems. Future research should be directed toward determining ways to diagnose and manage the disease that are efficient and easy to use in people with cognitive impairment.’
